Teleassisted Surgery for Gynecological Disease in Obese Patients - OB-ALFX
Phase II prospective single-institutional study.
Benign, Premalignant and Malignant Gynecological Disease Confined to the Pelvis
DEVICE: Telelap ALF-X
intraoperative complication rate, Operative time, conversion rate, estimated blood loss, visceral injury, intraoperative
postoperative complication rate, Ileus, bleeding, infection/sepsi, thrombosis, rehospitalization, death, 30 days
The aim of this Phase II prospective single-institutional study is to assess feasibility and early complications rate of Telelap ALF-X surgical treatment in obese patients affected by gynecological disease.